Yuka Kato, Koichi Azuma, Kakuhiro Yamaguchi, Toshihide Yokoyama, Shoichi Kuyama, Kota Sakamoto, Hideki Uno, Michihiro Yoshida, Kadoaki Ohashi. "A multi-institutional, single-arm, phase 2 study of durvalumab plus amrubicin in patients with relapsed extensive-stage small cell lung cancer (Aphrodite trial).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8105